KAERUS BIOSCIENCE LIMITED

Active London

Research and experimental development on biotechnology

6 employees website.com
Research and experimental development on biotechnology
K

KAERUS BIOSCIENCE LIMITED

Research and experimental development on biotechnology

Founded 12 Jul 2016 Active London, United Kingdom 6 employees website.com
Research and experimental development on biotechnology

Previous Company Names

FRAXADEV LIMITED 12 Jul 2016 — 23 Nov 2016
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation
Net assets £2M £245K 2024 year on year
Total assets £2M £526K 2024 year on year
Total Liabilities £317K £281K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

2nd Floor 168 Shoreditch High Street London E1 6RA United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for KAERUS BIOSCIENCE LIMITED (10274924), an active company based in London, United Kingdom. Incorporated 12 Jul 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

£2.06M

Decreased by £428.36k (-17%)

Net Assets

£1.83M

Decreased by £244.66k (-12%)

Total Liabilities

£316.97k

Decreased by £280.93k (-47%)

Turnover

N/A

Employees

6

Debt Ratio

15%

Decreased by 7 (-32%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

26 Allotments 72,423,166 Shares £14.03m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Oct 2024877,193€500k€0.57
1 Oct 2024561,404€320k€0.57
18 Jul 20241,140,351€650k€0.57
18 Jul 20242,851,316€1.63m€0.57
18 Jul 202443,421€25k€0.57

Officers

Officers

2 active 1 resigned
Status
Paul SekhriDirectorAmericanUnited States686 Oct 2023Active
Robert RingDirectorAmericanUnited States5812 Mar 2019Active

Shareholders

Shareholders (30)

Index Ventures Life Vi (jersey), L.p
25.0%
21,719,250
Index Ventures Life Vi (jersey), L.p
15.1%
13,147,825

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased
Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Apr 2026OfficersAppointment of Guenaelle Levoir as director on 2026-04-01
16 Apr 2026OfficersTermination of Howard Mayer as director on 2026-04-01
9 Dec 2025OfficersTermination of Michele Ollier as director on 2025-12-05
14 Oct 2025OfficersTermination of Paul Sekhri as director on 2025-10-01
2 Oct 2025ResolutionResolutions
16 Apr 2026 Officers

Appointment of Guenaelle Levoir as director on 2026-04-01

16 Apr 2026 Officers

Termination of Howard Mayer as director on 2026-04-01

9 Dec 2025 Officers

Termination of Michele Ollier as director on 2025-12-05

14 Oct 2025 Officers

Termination of Paul Sekhri as director on 2025-10-01

2 Oct 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Appointment of Guenaelle Levoir as director on 2026-04-01

6 days ago on 16 Apr 2026

Termination of Howard Mayer as director on 2026-04-01

6 days ago on 16 Apr 2026

Termination of Michele Ollier as director on 2025-12-05

4 months ago on 9 Dec 2025

Termination of Paul Sekhri as director on 2025-10-01

6 months ago on 14 Oct 2025

Resolutions

6 months ago on 2 Oct 2025